Serum Institute Of India

Adar Poonawalla Exclusive: 'Covishield Vaccine Safe, It Is Not Bulletproof Hence Wearing Masks Important'

Union Health Minister Launches India’s First Indigenous Pneumonia Vaccine By SII

Covid-19 Vaccine: 'Frivolous Claims Cause Skepticism,' SII CEO Proposes That Govt Protect Manufacturers

EXPLAINED | How To Register For Covid-19 Vaccine In India With Govt's Co-WIN App

Health Ministry Denies Reports Of Rejection Of SII, Bharat Biotech Emergency Use Authorisation

Bharat Biotech Applies For Emergency Authorization Of 'Covaxin', Becomes Second Indian Company To Seek Approval

PM Modi To Hold An All Party Meet On Dec 4 For Covid-19 Vaccine Roadmap

PM Modi Visits Zydus, Bharat Biotech, SII Labs To Review Corona Vaccine Development - All You Need To Know

Why AstraZeneca, Oxford 'Covishield' Vaccine A Better Fit Over Pfizer And Moderna Shots In India

Covid-19 Vaccine 'Covishield' To Be Ready By Jan 2021, Says Serum Institute CEO Adar Poonawalla

Serum Institute of India Gets DCGI Approval To Resume Oxford-AstraZeneca Covid-19 Vaccine Trials

Novavax- Serum Institute Come Together To Manufacture 'NVX‑CoV2373' COVID Vaccine; Aim To Increase Production To Over 2 Billion Doses